Literature DB >> 7707515

Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.

C Z Song1, P M Loewenstein, M Green.   

Abstract

Human adenovirus E1A proteins can repress the expression of several viral and cellular genes. By using a cell-free transcription system, we demonstrated that the gene product of the E1A 12S mRNA, the 243-residue protein E1A243R, inhibits basal transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR). The HIV-1 transactivator protein Tat greatly stimulates transcription from the viral promoter in vitro. However, E1A243R can repress Tat-activated transcription in vitro. Strong repression of both basal and Tat-activated transcriptions requires only E1A N-terminal amino acid residues 1 to 80. Deletion analysis showed that E1A N-terminal amino acids 4 to 25 are essential for repression, whereas amino acid residues 30 to 49 and 70 to 80 are dispensable. Transcriptional repression by E1A in the cell-free transcription system is promoter specific, since under identical conditions, transcription of the adenovirus major late promoter and the Rous sarcoma virus LTR promoter was unaffected. The repression of transcription by small E1A peptides in vitro provides an assay for investigation of molecular mechanisms governing E1A-mediated repression of both basal and Tat-activated transcriptions of the HIV-1 LTR promoter.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7707515      PMCID: PMC188988     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation.

Authors:  R W Gedrich; S T Bayley; D A Engel
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

Review 2.  HIV TAR: an RNA enhancer?

Authors:  P A Sharp; R A Marciniak
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

3.  HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.

Authors:  H Kato; H Sumimoto; P Pognonec; C H Chen; C A Rosen; R G Roeder
Journal:  Genes Dev       Date:  1992-04       Impact factor: 11.361

Review 4.  Transcriptional and transforming activities of the adenovirus E1A proteins.

Authors:  T Shenk; J Flint
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

Review 5.  The biochemistry of AIDS.

Authors:  Y N Vaishnav; F Wong-Staal
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

Review 6.  DNA tumor virus transforming proteins and the cell cycle.

Authors:  E Moran
Journal:  Curr Opin Genet Dev       Date:  1993-02       Impact factor: 5.578

7.  Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth.

Authors:  H G Wang; Y Rikitake; M C Carter; P Yaciuk; S E Abraham; B Zerler; E Moran
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

Review 8.  Does HIV-1 Tat induce a change in viral initiation rights?

Authors:  B R Cullen
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

9.  Phosphorylated CREB binds specifically to the nuclear protein CBP.

Authors:  J C Chrivia; R P Kwok; N Lamb; M Hagiwara; M R Montminy; R H Goodman
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

10.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

View more
  14 in total

1.  Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.

Authors:  C Suñé; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Adenovirus E1A proteins are closely associated with chromatin in productively infected and transformed cells.

Authors:  Maurice Green; Ninder K Panesar; Paul M Loewenstein
Journal:  Virology       Date:  2007-11-26       Impact factor: 3.616

3.  Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription.

Authors:  S F Parker; L K Felzien; N D Perkins; M J Imperiale; G J Nabel
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection.

Authors:  J L Cook; C K Krantz; B A Routes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

5.  HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator.

Authors:  L K Felzien; C Woffendin; M O Hottiger; R A Subbramanian; E A Cohen; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

6.  Expression of the Adenovirus Early Gene 1A Transcription-Repression Domain Alone Downregulates HER2 and Results in the Death of Human Breast Cancer Cells Upregulated for the HER2 Proto-Oncogene.

Authors:  Paul M Loewenstein; Maurice Green
Journal:  Genes Cancer       Date:  2011-07

7.  Transcription factor TFIID is a direct functional target of the adenovirus E1A transcription-repression domain.

Authors:  C Z Song; P M Loewenstein; K Toth; M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  The adenovirus E1A N-terminal repression domain represses transcription from a chromatin template in vitro.

Authors:  Paul M Loewenstein; Shwu-Yuan Wu; Cheng-Ming Chiang; Maurice Green
Journal:  Virology       Date:  2012-04-21       Impact factor: 3.616

9.  Adenovirus E1A N-terminal amino acid sequence requirements for repression of transcription in vitro and in vivo correlate with those required for E1A interference with TBP-TATA complex formation.

Authors:  Janice M Boyd; Paul M Loewenstein; Qing-quan Tang Qq; Li Yu; Maurice Green
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

10.  Ad E1A 243R oncoprotein promotes association of proto-oncogene product MYC with the NuA4/Tip60 complex via the E1A N-terminal repression domain.

Authors:  Ling-Jun Zhao; Paul M Loewenstein; Maurice Green
Journal:  Virology       Date:  2016-09-22       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.